Ligand validation:3KR0

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 3KR0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3KR0_SAH_A_3001	73%	14%	0.137	0.963	2.4	1.49	8	2	1	0	100%	1
3KR0_SAH_B_3002	62%	13%	0.161	0.955	2.38	1.62	7	4	2	0	100%	1
3KR2_SAH_B_3002	98%	15%	0.053	0.974	1.8	1.95	5	3	1	0	100%	1
3KQT_SAH_A_2001	98%	3%	0.056	0.976	4.17	2.08	11	4	2	0	100%	1
3KR1_SAH_B_3002	97%	10%	0.058	0.974	1.92	2.41	6	2	0	0	100%	1
2G71_SAH_A_2001	97%	48%	0.059	0.973	0.91	1.08	1	2	0	0	100%	1
2G8N_SAH_B_3002	96%	48%	0.062	0.973	0.87	1.12	-	2	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8TDR_SAH_B_1001	100%	25%	0.029	0.996	1.26	1.79	3	4	0	0	100%	1
6I73_SAH_A_401	100%	49%	0.028	0.992	0.78	1.16	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.